Financial News Feed

Weaker Buy Today ACAD ranks #969 as BUY CANDIDATE. Stronger Buy
Today ACAD ranks #969 as BUY CANDIDATE.

ACAD stock ACADIA Pharmaceuticals Inc.

ACAD stock
ACADIA Pharmaceuticals Inc.

Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) have been rivals in the Biotechnology for quite some time. Below is a review of each business including vario...

Read more

Checking in on some valuation rankings, ACADIA Pharmaceuticals Inc. (NasdaqGS:ACAD) has a Value Composite score of 87. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. Thes...

Read more

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Affimed N.V. (NASDAQ:AFMD) compete against each other in the Biotechnology sector. We will compare them and...

Read more

Both ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and AVROBIO Inc. (NASDAQ:AVRO) are Biotechnology companies, competing one another. We will contrast their profitability, analyst recommendations, institu...

Read more

We are comparing ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Innoviva Inc. (NASDAQ:INVA) on their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valua...

Read more

Since ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affec...

Read more

Wall Street analysts forecast that ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) will announce $59.30 million in sales for the current quarter, according to Zacks. Five analysts have issued estimates for ...

Read more

Sage Therapeutics Inc. (NASDAQ:SAGE) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) are two firms in the Biotechnology that compete against each other. Below is...

Read more

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and United Therapeutics Corporation (NASDAQ:UTHR) have been rivals in the Biotechnology for quite some time. Below is a review of each business including vari...

Read more

Both ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and Aileron Therapeutics Inc. (NASDAQ:ALRN) are Biotechnology companies, competing one another. We will compare...

Read more

Anika Therapeutics Inc (ANIK) investors sentiment decreased to 0.87 in Q4 2018. It’s down -0.28, from 1.15 in 2018Q3. The ratio is negative, as 62 investment professionals increased or opened new st...

Read more

Acadia Pharmaceuticals Inc (ACAD) investors sentiment increased to 1.11 in 2018 Q4. It’s up 0.19, from 0.92 in 2018Q3. The ratio increased, as 78 investment professionals increased or started new ho...

Read more

Murphy USA Inc. (NYSE:MUSA) has a Q.i. Value of 22.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose ...

Read more

Cellect Biotechnology Ltd. (NASDAQ:APOP) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) have been rivals in the Biotechnology for quite some time. Below is a...

Read more

Pain Therapeutics Inc. (NASDAQ:PTIE) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), both competing one another are Biotechnology companies. We will compare their profitability, institutional ownership...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank